| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9224560 | Clinics in Dermatology | 2005 | 12 Pages |
Abstract
Advances in biotechnological methods have helped to create designer molecules and proteins that specifically recognize target receptors and chemicals that modify their actions. These drugs, termed “biologic response modifiers,” are now being studied as specific immunosuppressive agents producing different T-cell and cytokine effects in psoriasis.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Ibrahim MD, Mohamed Omar MD, Hassan MD,